Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Blood and Marrow Transplant (BMT) for Sickle Cell Disease
source: The Sickle Cell Community Consortium
year: 2019
summary/abstract:This handbook was developed to answer common questions about BMT. Please share any questions you may have after reviewing this brochure with your health care team.
In the past, only children who had major complications from their sickle cell disease (such as a stroke) were eligible for BMT. Since we know most children do very well after BMT using a matched sibling donor, more children are undergoing BMT today. In addition, we are now learning that adult sickle cell patients can tolerate BMT better than we expected with positive results, particularly those with a matched sibling donor.
Most children and many adults with sickle cell disease may be eligible for BMT if they have a matched sibling donor. What if I or my child do not have a matched sibling?
read more
+myBinderRelated Content
-
Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRI...Background: Hematopoietic cell transplan...
-
Sickle cell cure is real, as this Kansas patient provesIntense pain. Fatigue. Repeated infectio...
-
Today’s Faces of Sickle Cell Disease: Courtney Fitzhugh, M.D.Courtney Fitzhugh first became intereste...
-
Health-related quality of life at 1 Year in the drepagreffe trial comparing chronic transfusion to transplantation i...Health is not just defined as the absenc...
-
Today’s Faces of Sickle Cell Disease: Kirti DasuKirti Dasu was born in South East India ...
-
Allistair Abraham, MDAllistair Abraham is currently affiliate...
-
Gene therapy targets sickle-cell diseaseElliott Vichinsky estimates that at leas...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.